International Programs
-
-
European Commission
U.S. FDA - EUROPEAN UNION
Table of Contents
Confidentiality Commitments on Cosmetics
- USFDA (July 2, 2007)
USFDA and European Agency for the Evaluation of Medicinal Products
- Program to rationalize international GMP inspections of active pharmaceutical ingredients/active substances manufacturers - February 2012
- Enhancing GMP Inspection Cooperation between EMA and FDA, December 5 2011
- Report on the Pilot EMA-FDA GCP Initiative, September 2009 – March 2011
- Frequently Asked Questions and Answers for the Report on the Pilot EMA-FDA GCP Initiative, September 2009 – March 2011
- Final report on the International API inspection Pilot Programme, May 2011
- Medicines Regulation: Transatlantic Administration Simplification Action Plan: Implementation Report - 2010 (Published July 27, 2011) | Pdf Format [98 KB]
- Interactions between the European Medicines Agency and U.S. Food and Drug Administration September 2009-September 2010 (June 2011)
- Announcement that the FDA and EMA have received first parallel quality-by-design application
- EMA-FDA pilot program for parallel assessment of Quality by Design applications (March 16, 2011)
- FDA New Release: FDA, EMA announce pilot for parallel assessment of Quality by Design applications (March 16, 2011)
- U.S.FDA - European Medicines Agency Good Clinical Practice Initiative Frequently Asked Questions and Answers
- EMA-FDA GCP Initiative - Terms of engagement and procedures for participating authorities (Pilot Phase (18 months): Start date 01 September 2009)
- Medicines Regulation: Transatlantic Administration Simplification Action Plan: Implementation Report - 2009 (October 26, 2009)
- General Principles EMA - FDA Parallel Scientific Advice (July 22, 2009)
- Update on a pilot project to collaborate on international GMP inspection activities (January 8, 2009)
- EU Pilot Project on active pharmaceutical ingredient (API) manufacturer inspections
- Transatlantic Cooperation in Pharmaceutical Regulation: Identifying Opportunities for Administrative Simplification (December 4, 2007)
- Confidentiality Arrangements Concluded between the EU (EC and EMA) and the US FDA/DHHS - Implementation Plan for Medicinal Products for Human Use (Updated June 2007)
- Project Outline: A common application format for orphan medicinal product designation in the European Union and the United States (June, 2007)
- Principles of Interactions: between EMA and FDA Pediatric Therapeutics (June, 2007)
- EU (European Commission and EMA) and FDA Agree on Guiding Principles for Joint FDA EMA Voluntary Genomic Data Submission Briefing Meetings (May 21, 2006)
- Cooperation on Drug Regulation Strengthened (March 14, 2006)
- Confidentiality Arrangements Concluded Between The EU (EC and EMA) and AND The US FDA/DHHS Implementation Plan for Medicinal Products for Human Use (September 16, 2004)
- Arrangements
- Extension (Letter of Exchange) - (September 12, 2005)
- FDA - Letter of Exchange - (September 12, 2003)
- EC/EMA - Letter of Exchange (September 12, 2003)
- Extension (Letter of Exchange) - (September 12, 2005)
USFDA and Health and Consumer Protection Directorate-General, (DG SANCO)
- Confidentiality Commitments
- FDA Commitment (June 6, 2005)
- DG SANCO Commitment (June 6, 2005)
- FDA Commitment (June 6, 2005)
- Implementation Plan on the Sharing of Confidential Information (September 23, 2005)
Confidentiality Commitments on Medical Devices
- USFDA - (July 2, 2007)
GHTF - Pilot Program
- FDA Extends Pilot Program for Evaluation of Globally Harmonized Medical Device Premarket Applications Until July 2006 (The STED Initiative)
Implementation Work Plan for Veterinary Medicinal Products
Parallel Scientific Advice for Veterinary Medicinal Products
- General Principles - FDA/Center for Veterinary Medicine - EMA/Veterinary Medicines and Inspections Unit - Parallel Scientific Advice Meetings (May 22, 2008).
-
-







